Company Overview and News

Waste Management profit rises in 2017

Waste Management, New Zealand's biggest waste collection and recycling company, drove up sales and profit last year as economic growth underpinned volumes of industrial and construction sector waste and it added landfill capacity.

Decades-long apprenticeship of Li Ka-shing's son is finally over

Whispering in dad's ear: Hong Kong tycoon Li Ka-shing, right, chairman of CK Hutchison Holdings company, chats with his son, co-managing directors Victor Li attend a press conference to announce the company's annual results in Hong Kong, Friday, March 16, 2018. Hong Kong billionaire Li said Friday he is retiring as chairman of his sprawling conglomerate and handing control to his eldest son. - AP

Victor Li finally emerges from the shadow of his Superman father Li Ka-shing

2018-03-16 scmp
Victor, a Stanford University-educated engineer, takes over control of CK Hutchison Holdings and CK Asset Holdings after a decades-long apprenticeship under his illustrious father

Shares of Li Ka-shing’s Power Assets surge on special dividend and higher profit 

2018-03-16 scmp
The Hong Kong-listed utilities company makes a net profit of HK$8.32 billion for 2017, beating analysts’ estimates

Australia formalises checks on foreign ownership of electricity assets amid growing Chinese influence

2018-02-01 scmp
Australia has vowed to impose formal restrictions on foreign investment in its electricity sector – where bids from mainland China and Hong Kong have previously been rejected on grounds of national interest – ahead of a federal election that could take place as soon as this year.

Foreign-backed investors are pocketing £200m a year from Britain's privatised railways just by leasing them trains - Mirror Online

And the RMT union reveals train passengers would see their fares cut by 2.1 per cent if 'rip-off' was ended

CK Hutchison H1 profit rises 7 pct, meets forecasts

2017-08-03 reuters
HONG KONG, Aug 3 (Reuters) - CK Hutchison Holdings Ltd , the ports-to-telecoms arm of billionaire businessman Li Ka-shing, posted a 7-percent rise in first-half net profit on Thursday, buoyed by strength in its telecoms business in Europe.

Acquisitions, economic growth drive sales at Beijing Capital's Waste Management NZ

Waste Management, New Zealand's biggest waste collection and recycling company, lifted sales by 2.3 per cent in 2016 through a combination of acquisitions and increased demand and says it is enjoying another year of growth.

Canada Oil, Gas Assets Beat US in Clash for Foreign Cash

2017-06-20 rigzone
Investors from outside North America busting into the continent’s oil and gas business are increasingly more likely to make a buy in Canada than in the United States, a recent Firmex report with Mergermarket found.

Li Ka-shing's firms slump as pound falls

Li Ka-shing’s (pic) CK Hutchison Holdings Ltd and Cheung Kong Infrastructure Holdings Ltd were among the biggest losers in Hong Kong trading, as the slumping pound cut the value of the companies’ UK earnings. Sterling slid 2% after Britain’s ruling party lost its majority in a snap election.

Li Ka-Shing’s firms slump as falling pound hurts profit outlook

2017-06-09 themalaymailonline
Li has much riding on Britain as the country is the biggest profit generator at the billionaire’s business empire. — AFP picHONG KONG, June 9 ― A hung parliament in the UK is translating into losses for one of Asia’s richest men.

Chinese investment in Australia surges 11.7pc as deals hit record US$11.5b

2017-05-01 scmp
Record 103 deals signed with Chinese companies in 2016, with 76pc of those reached with private firms

Chinese investment in Australia surged 11.7 per cent to $15.4b last year: report

Chinese investment in Australia surged 11.7 per cent last year to $15.4 billion amid booming demand for agricultural assets and infrastructure, according to a report released on Monday.

Chinese investment in Australia surged 11.7 per cent to $15.4b last year: report

Chinese investment in Australia surged 11.7 per cent last year to $15.4 billion amid booming demand for agricultural assets and infrastructure, according to a report released on Monday.

Annual Financial Report 2016

2017-04-28 londonstockexchange
Unit 607, 6th Floor, FWD Financial Centre, 308 Des Voeux Road Central, Sheung Wan, Hong Kong

Related Articles

SGMO: Sangamo BioSciences and Research Report

2018-05-19 - Asif

OVERVIEW Sangamo BioSciences is a clinical stage biotechnology company focused on translating ground-breaking science into genomic therapies that transform patients’ lives using its industry-leading platform technologies in genome editing, gene therapy, gene regulation and cell therapy. Sangamo BioSciences is a leader in the research and development of zinc finger proteins, or ZFPs, a naturally occurring class of proteins found in humans. Sangamo BioSciences has used its knowledge and expertise to develop a proprietary technology platform in both genome editing and gene regulation. ZFPs can be engineered to make zinc finger nucleases, or ZFNs, proteins that can be used to specifically modify DNA sequences by adding or knocking out specific genes, or genome editing, and ZFP transcription factors or ZFP TFs, proteins that can be used to increase or decrease gene expression, or gene regulation. In the process of developing this platform, Sangamo BioSciences has accrued signific...

HMNY: Helios and Matheson Analytics and Research Report

2018-05-19 - Asif

Business Overview The company provide high quality information technology, or IT, services and solutions including a range of technology platforms focusing on big data, business intelligence, and consumer-centric technology. More recently, to provide greater value to stockholders, the Company has sought to expand its business primarily through acquisitions that leverage its capabilities and expertise. As of March 31, 2018, the Company owned 81.2%, and as of the date of this report the Company owns 91.8%, of the outstanding shares of MoviePass (excluding outstanding MoviePass options and warrants). MoviePass is the premiere movie theater subscription service in the United States which provides its subscribers the ability to view up to one new movie title per day for one monthly subscription price. The company's more than 2 million subscribers have access to see films in over 91% of U.S movie theaters. By the end of April 2018, the company implemented certain measures ...

BSTG: Biostage Analysis and Research Report

2018-05-17 - Asif

Overview Biostage is a biotechnology company developing bioengineered organ implants based on its novel CellframeTM technology. The company's Cellframe technology is comprised of a biocompatible scaffold that is seeded with the recipient’s own stem cells. This technology is being developed to treat life-threatening conditions of the esophagus, trachea or bronchus with the objective of dramatically improving the treatment paradigm for those patients. The company believe that its Cellframe technology will provide surgeons with new ways to address damage to the esophagus, bronchus, and trachea due to congenital abnormalities, cancer, infection or trauma. Products being developed based on its Cellframe technology for those indications are called CellspanTM products. The company announced favorable preliminary pre-clinical results of large-animal studies for the esophagus, trachea and bronchus in November 2015. Since then, the Cellspan esophageal implant product candidates hav...